NewsIn memory
Remembering Sven-Göran Eriksson and Understanding Pancreatic Cancer
Former England manager Sven-Göran Eriksson died of pancreatic cancer in 2024. Here is what pancreatic cancer means, explained calmly and plainly.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What Eriksson and his family said
In January 2024, Sven-Göran Eriksson announced that he had been diagnosed with terminal pancreatic cancer. The Football Association confirmed that timeline in its tribute after his death. ITV News reported that he had been given about a year to live.
He died on 26 August 2024, aged 76, at his home in Björkefors, Sweden. His children said he "fell asleep peacefully," and added: "Dad told us at the beginning of this year about his serious illness and received an amazing response from friends and football fans around Europe. He has for a long time fought bravely with his illness, but now it came to an end."
That is the public account, and this article does not go past it. What is worth unpacking is the language, because "terminal" and "a year" are two of the most misread phrases in medicine.
What a prognosis number actually is
When a doctor says something like "about a year," they are almost always quoting a median. A median is the midpoint of a group. If a hundred people with similar disease were followed, half would still be alive at that point and half would not.
That means the number describes a spread, not a date. Some people live much less time. Some live far longer. Nothing in the statistic says which position any one person occupies.
Nor is it fixed. Prognosis figures come from people treated in the past, with the drugs available then. None of that makes the number meaningless. It makes it a planning tool rather than a verdict.
The disease behind the word
Pancreatic cancer is uncommon but very deadly. For 2026 the American Cancer Society projects 67,530 new cases and 52,740 deaths in the United States, a count the National Cancer Institute passes along in its PDQ summary. It ranks as the fourth leading cause of cancer death in men and the third in women. NCI adds that despite that toll, the causes of the disease are poorly understood.
Most pancreatic cancers are adenocarcinomas of the exocrine pancreas, the part that makes digestive enzymes. NCI lists the risk factors as a family history of the disease, cigarette smoking, obesity, chronic pancreatitis, and certain genetic conditions, including those linked to the BRCA1, BRCA2, PALB2, and ATM genes.
NCI names three specific reasons this cancer is so often found late. There are no noticeable signs or symptoms in the early stages. When signs appear, they resemble other illnesses such as pancreatitis or an ulcer. And the pancreas is hidden behind other organs, which makes it hard to see clearly on scans.
Blood testing does not fix that. NCI states that no tumor-specific markers exist for pancreatic cancer, and that CA 19-9, the marker most often used, has low specificity.
When to get checked
NCI lists these signs as the cancer grows:
- Jaundice, meaning yellowing of the skin or eyes.
- Light-colored stools or dark urine.
- Pain in the upper or middle abdomen and in the back.
- Weight loss for no known reason.
- Loss of appetite.
- Fatigue.
Thresholds worth acting on:
- Yellowing of the eyes or skin in an adult, with no fever, needs medical attention within days. Painless jaundice is the classic presentation and it is never routine.
- Pale stools with dark urine, for more than a few days.
- Upper abdominal pain that radiates through to the back, is worse lying flat, and eases when leaning forward, lasting more than two weeks.
- Weight loss you did not intend, over one to two months, especially with appetite loss.
There is no screening program for pancreatic cancer in people at average risk. If two or more close relatives have had it, or there is a known BRCA-related gene change in the family, genetic counseling is worth asking about.
What treatment does when cure is not the goal
NCI is candid. Surgery is the mainstay of curative treatment. It helps only with small, localized tumors, and it should sit alongside systemic drug therapy. People with unresectable, metastatic, or recurrent disease are unlikely to benefit from surgery. NCI notes that patients at any stage are candidates for clinical trials, because standard treatments work poorly.
When cure is off the table, the work does not stop. NCI lists palliative measures that can improve quality of life: draining a blocked bile duct surgically or with imaging guidance, relieving obstruction where the stomach empties, controlling pain, and providing psychological care for the effects of the diagnosis and treatment.
That is not the same as giving up, and NCI is explicit about the distinction. Palliative care is care meant to improve quality of life for people with a serious or life-threatening disease. It can be given with or without curative care, and anyone can receive it regardless of age or stage.
NCI also draws the line with hospice. Palliative care can begin at any point during cancer treatment. Hospice care begins when curative treatment is no longer the goal and the sole focus is quality of life.
The evidence for starting early is real. NCI reports that some studies show a benefit from adding palliative care to usual cancer care soon after a diagnosis of advanced cancer. It can improve quality of life and mood, and may even prolong survival.
The practical version: a palliative care team can be requested at diagnosis, not at the end. Ask the oncologist.
What the numbers show, and what they cannot
These are group statistics. They describe populations and predict nothing about a person.
SEER, the federal cancer statistics program, publishes American Cancer Society projections of 67,530 new pancreatic cancers in the United States in 2026 and 52,740 deaths, about 8.4% of all cancer deaths. Five-year relative survival across all stages is 13.7% for people diagnosed from 2016 to 2022. Pancreatic cancer is most often diagnosed between the ages of 65 and 74.
Stage explains most of the spread. SEER records five-year relative survival of 43.6% for localized disease, 17.0% for regional disease, and 3.4% once the cancer has reached distant organs. Only about 15% are found while localized. Roughly 51% are already distant at diagnosis.
NCI's clinician guidance is equally blunt about exocrine pancreatic cancer: it is rarely curable, with an overall survival rate below 6%, and truly localized disease accounts for less than 20% of cases.
Eriksson lived about eight months after his announcement. That is a fact about one man's illness. It forecasts nothing for anyone else. The lesson that does travel is smaller. A prognosis is a midpoint drawn from other people. Care continues after the word "terminal" is used, and it can start earlier than most people think.
Sources
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Pancreatic cancer. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.